Top 10 China Blood Screening Manufacturers

Blood screening is a critical component of global healthcare systems, ensuring the safety of blood supplies through advanced detection of infectious diseases such as HIV, HBV, and HCV. China has emerged as a key player in this field, with its manufacturers leveraging cutting-edge technologies like nucleic acid testing (NAT) and chemiluminescence immunoassays (CLIA) to produce high-precision, cost-effective solutions. These companies adhere to international standards (e.g., ISO 13485, CE, and FDA approvals) and serve domestic and global markets through robust R&D and strategic partnerships. Below, we highlight ten leading Chinese blood screening manufacturers driving innovation and reliability in this vital industry.

 

1. Hangzhou Biotest Biotech Co., Ltd.

Hangzhou Biotest Biotech is a renowned high-tech enterprise specializing in in vitro diagnostic (IVD) products, including blood screening solutions. The company excels in developing NAT and CLIA kits for detecting HIV, HBV, HCV, and other pathogens. With ISO 13485 certification and CE-marked products, Biotest emphasizes rigorous quality control and technological innovation. Its global distribution network and OEM/ODM services make it a trusted partner for ensuring blood safety worldwide.

 

2. Wantai BioPharm

Wantai BioPharm is a leader in infectious disease diagnostics, focusing on ELISA and CLIA-based blood screening assays. Its products are widely used for high-sensitivity detection of viral markers, supported by strong R&D and FDA approvals. Wantai's global impact stems from its commitment to accuracy and scalability.

 

3. Mindray

Mindray, a global IVD giant, offers integrated blood screening solutions, including fully automated CLIA systems and NAT platforms. Its products combine high throughput with reliability, catering to large-scale blood banks and hospitals. Mindray's focus on innovation ensures cutting-edge performance.

 

4. Sansure Biotech

Sansure Biotech pioneers molecular diagnostics, providing NAT systems for blood-borne pathogen detection. Its kits feature rapid turnaround times and high specificity, meeting stringent international standards. Sansure's solutions are exported to over 100 countries, underscoring its global reach.

 

5. BioGerm

BioGerm specializes in blood screening reagents and instruments, with a focus on CLIA and ELISA technologies. Its products are known for stability and ease of use, serving blood centers across China and emerging markets. The company invests heavily in R&D to enhance assay sensitivity.

 

6. Livzon Diagnostics

Livzon Diagnostics delivers comprehensive blood screening panels using CLIA and NAT methods. Its robust product portfolio ensures accurate detection of infectious diseases, backed by CE certification. Livzon's strong distribution network reinforces its market presence.

 

7. Basecare Medical

Basecare Medical focuses on NAT solutions for blood screening, emphasizing automation and multiplex detection. Its platforms reduce operational complexity while maintaining high accuracy. The company targets OEM collaborations to expand its global footprint.

 

8. Hotgen Biotech

Hotgen Biotech develops innovative blood screening assays, including multiplex NAT kits for simultaneous pathogen detection. Its products offer cost-efficiency and high throughput, ideal for resource-limited settings. Hotgen's research-driven approach fuels continuous improvement.

 

9. DaAn Gene

DaAn Gene, a subsidiary of Sun Yat-sen University, is a key player in molecular diagnostics. Its blood screening NAT kits are praised for precision and compliance with international norms. DaAn Gene collaborates with global health organizations to promote safe blood transfusion.

 

10. Getein Biotech

Getein Biotech provides CLIA-based blood screening systems, integrating instrument and reagent manufacturing. Its user-friendly platforms ensure rapid and reliable results for medium-to-high volume labs. Getein's focus on affordability expands access to quality diagnostics.